छोड़कर सामग्री पर जाएँ

Strides Pharma Q3 consolidated net loss at Rs 82 crore

Revenue from operations rose to Rs 865 crore for the quarter under review as against Rs 794 crore in the year-ago period

Read More

​ Revenue from operations rose to Rs 865 crore for the quarter under review as against Rs 794 crore in the year-ago period Revenue from operations rose to Rs 865 crore for the quarter under review as against Rs 794 crore in the year-ago period  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी